Skip to main content

Table 12 Difference in means between treatment and control groups for SBP at final follow-up

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Author

Sample size (treatment group vs. control group)

Difference

95% CI

Liu et al. [64]

119 (60 vs. 59)

− 1.00 mmHg**

− 3.87 to 1.87

Mainenti et al. [65]

23 (11 vs. 12)

− 12.25 mmHg*

− 29.53 to 5.03

Monzani et al. [67]

20 (10 vs. 10)

0.50 mmHg*

− 6.79 to 7.79

Monzani et al. [68]

45 (23 vs. 22)

− 2.00 mmHg*

− 10.19 to 6.19

Nagasaki et al. [69]

95 (48 vs. 47)

− 3.40 mmHg**

− 10.56 to 3.76

Stott et al. [73]

638 (318 vs. 320)

− 0.1 mmHg*

− 2.1 to 2.4

Yazici et al. [76]

45 (23 vs. 22)

0.50 mmHg*

− 5.23 to 6.23

Zhao et al. [77]

369 (210 vs. 159)

− 2.54 mmHg*

− 6.65 to 1.57

  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group